KURA (STOCKS)
Kura Oncology, Inc.
$9.540000
+0.490000 (+5.41%)
Prev close: $9.050000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Troy E. Wilson
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $846.91M
- Employees
- 192
- P/E (TTM)
- -2.85
- P/B (TTM)
- 7.45
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
13
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.83 | $-0.65 | -0.1844 | -28.56% |
|
Dec 2025 (Q4)
|
$-0.92 | $-0.49 | -0.4254 | -86.01% |
|
Sep 2025 (Q3)
|
$-0.85 | $-0.87 | +0.0188 | +2.16% |
|
Jun 2025 (Q2)
|
$-0.75 | $-0.47 | -0.2819 | -60.22% |
Financial Statements
| Revenues | $71.64M |
| Benefits Costs and Expenses | $366.13M |
| Costs And Expenses | $371.62M |
| Nonoperating Income/Loss | $23.26M |
| Operating Expenses | $389.12M |
| Selling, General, and Administrative Expenses | $128.70M |
| Research and Development | $260.36M |
| Operating Income/Loss | -$317.75M |
| Income/Loss From Continuing Operations After Tax | -$294.57M |
| Income/Loss From Continuing Operations Before Tax | -$294.49M |
| Income Tax Expense/Benefit | $79.00K |
| Net Income/Loss | -$294.57M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$294.57M |
| Net Income/Loss Available To Common Stockholders, Basic | -$294.57M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.35 |
| Diluted Earnings Per Share | -$3.35 |
| Basic Average Shares | 263,967,000 |
| Diluted Average Shares | 263,967,000 |
| Assets | $652.55M |
| Current Assets | $623.78M |
| Inventory | $843.00K |
| Other Current Assets | $622.94M |
| Noncurrent Assets | $28.77M |
| Fixed Assets | $7.61M |
| Other Non-current Assets | $21.16M |
| Liabilities | $544.67M |
| Current Liabilities | $101.50M |
| Accounts Payable | $7.04M |
| Wages | $10.47M |
| Other Current Liabilities | $83.99M |
| Noncurrent Liabilities | $443.17M |
| Equity | $107.88M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $107.88M |
| Liabilities And Equity | $652.55M |
| Net Cash Flow From Operating Activities | -$77.99M |
| Net Cash Flow From Operating Activities, Continuing | -$77.99M |
| Net Cash Flow From Investing Activities | $64.08M |
| Net Cash Flow From Investing Activities, Continuing | $64.08M |
| Net Cash Flow From Financing Activities | $1.72M |
| Net Cash Flow From Financing Activities, Continuing | $1.72M |
| Net Cash Flow | -$12.19M |
| Net Cash Flow, Continuing | -$12.19M |
| Comprehensive Income/Loss | -$295.92M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$295.92M |
| Other Comprehensive Income/Loss | $196.31M |